ERLONAT – Erlotinib 100 mg and 150 mg. is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, and Name patient medicine.
Patients with this medication may experience mild rashes as well as infections. Immediately seek help from your medical team in order to receive proper treatment.
What is ERLONAT ™?
ERLONAT is indicated for :
- Maintenance treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.
- Treatment of locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.
- First-line treatment of patients with locally advanced or metastatic pancreatic cancer, in combination with gemcitabine.
Uses Of Erlotinib
Erlonat (Erlotinib) specifically indicated for the treatment of Non-Small Cell Lung Cancer (NSCLC). Also, Erlotinib the FDA approved medication for use in the patient with Pancreatic Cancer.
Take this medication as your health care provider has instructed. You should swallow an entire tablet at the same time each day for better outcomes. Never try to take any dose in additional quantity. Do not start or stop a specific dose by yourself until you get words from your doctor.
How Erlonat Tablet Works?
Erlonat is an Epidermal Growth Factor Receptor Inhibitor and it works by targeting and binding the Epidermal Growth Factor Receptor Tyrosine Kinase, which is rarely mutated in numerous forms of certain cancer. In reversible fashion, it binds ATP (Adenosine Triphosphate). Erlonat mainly works by blocking and resisting the abnormal protein that signals in developing the cancer cells. In the year 2004, this medication was approved by the FDA for medical use in the United States.